Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional study

por Parkin, Georgia M., Thomas, Elizabeth A., Corey-Bloom, Jody
Publicado 2023

Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

por Gutierrez, Ashley, Corey-Bloom, Jody, Thomas, Elizabeth A., Desplats, Paula
Publicado 2020

The signal intensity variation of multiple sclerosis (MS) lesions on magnetic resonance imaging (MRI) as a potential biomarker for patients’ disability: A feasibility study

por Sedaghat, Sam, Jang, Hyungseok, Athertya, Jiyo S., Groezinger, Martin, Corey-Bloom, Jody, Du, Jiang
Publicado 2023

Plasma neurofilament light in Huntington’s disease: A marker for disease onset, but not symptom progression

por Parkin, Georgia M., Corey-Bloom, Jody, Snell, Chase, Castleton, Jordan, Thomas, Elizabeth A.
Publicado 2021

The relationship between dementia severity and rest/activity circadian rhythms

por Gehrman, Phil, Marler, Matthew, Martin, Jennifer L, Shochat, Tamar, Corey-Bloom, Jody, Ancoli-Israel, Sonia
Publicado 2005

Salivary levels of total huntingtin are elevated in Huntington’s disease patients

por Corey-Bloom, Jody, Haque, Ameera S., Park, Sungmee, Nathan, Ajay S., Baker, Robert W., Thomas, Elizabeth A.
Publicado 2018

Clinical evaluation of white matter lesions on 3D inversion recovery ultrashort echo time MRI in multiple sclerosis

por Sedaghat, Sam, Jang, Hyungseok, Ma, Yajun, Afsahi, Amir Masoud, Reichardt, Benjamin, Corey-Bloom, Jody, Du, Jiang
Publicado 2023

Measurement of T1 of the Ultrashort T2* Components in White Matter of the Brain at 3T

por Du, Jiang, Sheth, Vipul, He, Qun, Carl, Michael, Chen, Jun, Corey-Bloom, Jody, Bydder, Graeme M.
Publicado 2014

Salivary Huntingtin protein is uniquely associated with clinical features of Huntington’s disease

por Parkin, Georgia M., Corey-Bloom, Jody, Snell, Chase, Smith, Haileigh, Laurenza, Angela, Daldin, Manuel, Bresciani, Alberto, Thomas, Elizabeth A.
Publicado 2023

Development and Psychometric Properties of a New Brief, Yet Comprehensive, Behavioral Questionnaire for Huntington's Disease

por Hughes, Shelby, Aboufadel, Sameer, Smirnova, Anna, Snell, Chase, Churchill, Emma, Hall, Andrew, Malcarne, Vanessa, Gilbert, Paul E., Corey‐Bloom, Jody
Publicado 2023

Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients

por Corey-Bloom, Jody, Haque, Ameera, Aboufadel, Sameer, Snell, Chase, Fischer, Ryan S., Granger, Steven W., Granger, Douglas A., Thomas, Elizabeth A.
Publicado 2020

Assessing the state of care for Huntington disease in the United States: Results from a survey of practices treating Huntington disease patients

por Seeberger, Lauren, Corey-Bloom, Jody, O'Brien, Michael, Slowiejko, Diana, Schlang, Danielle, Booth, Marika S., Ann Griffin, Beth, Chen, Peggy G.
Publicado 2022

Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington’s Disease Patients and Healthy Control Subjects

por Corey-Bloom, Jody, Fischer, Ryan S., Kim, Aeri, Snell, Chase, Parkin, Georgia M., Granger, Douglas A., Granger, Steven W., Thomas, Elizabeth A.
Publicado 2020

LASSI-L detects early cognitive changes in pre-motor manifest Huntington’s disease: a replication and validation study

por Sierra, Luis A., Hughes, Shelby B., Ullman, Clementina J., Hall, Andrew, Pandeya, Sarbesh R., Schubert, Robin, Frank, Samuel A., Halko, Mark A., Corey-Bloom, Jody, Laganiere, Simon
Publicado 2023

Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease

por Claassen, Daniel O., Corey-Bloom, Jody, Dorsey, E. Ray, Edmondson, Mary, Kostyk, Sandra K., LeDoux, Mark S., Reilmann, Ralf, Rosas, H. Diana, Walker, Francis, Wheelock, Vicki, Svrzikapa, Nenad, Longo, Kenneth A., Goyal, Jaya, Hung, Serena, Panzara, Michael A.
Publicado 2020